Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain

ClinicalTrials.gov ID: NCT05620563

Public ClinicalTrials.gov record NCT05620563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3857210 for the Treatment of Osteoarthritis Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of LY3857210 in participants with Osteoarthritic Pain. This trial is part of the chronic pain master protocol, H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.

Study identification

NCT ID
NCT05620563
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
147 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 22, 2022 (Actual)
Primary completion
Jun 5, 2023 (Actual)
Completion
Jun 12, 2023 (Actual)
Last update posted
Jun 26, 2024

2022 – 2023

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Synexus Clinical Research US, Inc. Chandler Arizona 85224 —
Arizona Research Center Phoenix Arizona 85053 —
Artemis Institute for Clinical Research Riverside California 92503 —
Artemis Institute for Clinical Research San Diego California 92103 —
CMR of Greater New Haven, LLC Hamden Connecticut 06517 —
Accel Research Sites- Clinical Research Unit DeLand Florida 32720 —
Suncoast Research Group Miami Florida 33135 —
University of Miami Miami Florida 33136 —
New Horizon Research Center Miami Florida 33165 —
Renstar Medical Research Ocala Florida 34470 —
Synexus Clinical Research US, Inc - Orlando Orlando Florida 32806 —
Synexus Clinical Research US, Inc. Pinellas Park Florida 33781 —
North Georgia Clinical Research Woodstock Georgia 30189 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
Northwestern University Chicago Illinois 60611 —
Boston Clinical Trials Boston Massachusetts 02131 —
ActivMed Practices and Research Methuen Massachusetts 01844 —
MedVadis Research Corporation Waltham Massachusetts 02451 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Clinvest Research LLC Springfield Missouri 65807 —
Lillestol Research Fargo North Dakota 58104 —
META Medical Research Institute Dayton Ohio 45432 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Synexus Clinical Research US, Inc. San Antonio Texas 78229 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05620563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05620563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →